Australia markets closed

Carl Zeiss Meditec AG (AFX.SW)

Swiss - Swiss Delayed price. Currency in USD
Add to watchlist
- (-)
As of 03:55PM CEST. Market open.
Currency in

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.93
52-week change 30.03%
S&P500 52-week change 327.84%
52-week high 3174.60
52-week low 3174.55
50-day moving average 3174.58
200-day moving average 3174.56

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 836.57M
% held by insiders 159.14%
% held by institutions 124.19%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 31.10
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Sept 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 12.67%
Operating margin (ttm)13.76%

Management effectiveness

Return on assets (ttm)7.03%
Return on equity (ttm)12.83%

Income statement

Revenue (ttm)2.06B
Revenue per share (ttm)23.12
Quarterly revenue growth (yoy)-6.40%
Gross profit (ttm)N/A
EBITDA 340.94M
Net income avi to common (ttm)261.22M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)-25.00%

Balance sheet

Total cash (mrq)15.34M
Total cash per share (mrq)0.17
Total debt (mrq)142.01M
Total debt/equity (mrq)6.74%
Current ratio (mrq)3.51
Book value per share (mrq)23.42

Cash flow statement

Operating cash flow (ttm)263.28M
Levered free cash flow (ttm)49.06M